Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Targeting mTOR signaling for lung cancer therapy.

× No keyword cloud information.

6 in total

1. Expression of phosphorylated mTOR and its clinical significances in small cell lung cancer.

Authors: Ji Hyun Lee; Kyung Woo Kang; Hyoun Wook Lee
Journal: Int J Clin Exp Pathol Date: 2015-03-01

2. New molecular targeted therapies for advanced non-small-cell lung cancer.

Authors: Míriam Méndez; Ana Custodio; Mariano Provencio
Journal: J Thorac Dis Date: 2011-03 Impact factor: 2.895

3. Phase 1 and pharmacokinetic study of everolimus, a mammalian target of rapamycin inhibitor, in combination with docetaxel for recurrent/refractory nonsmall cell lung cancer.

Authors: Suresh S Ramalingam; R Donald Harvey; Nabil Saba; Taofeek K Owonikoko; John Kauh; Dong M Shin; Shi-Yong Sun; Sandra Strychor; Mourad Tighiouart; Merrill J Egorin; Haian Fu; Fadlo R Khuri
Journal: Cancer Date: 2010-08-15 Impact factor: 6.860

4. Phase II study of docetaxel in combination with everolimus for second- or third-line therapy of advanced non-small-cell lung cancer.

Authors: Suresh S Ramalingam; Taofeek K Owonikoko; Madhusmita Behera; Janakiraman Subramanian; Nabil F Saba; Scott A Kono; Anthony A Gal; Gabriel Sica; R Donald Harvey; Zhengjia Chen; Carmen M Klass; Dong M Shin; Haian Fu; Shi-yong R Sun; Ramaswamy Govindan; Fadlo R Khuri
Journal: J Thorac Oncol Date: 2013-03 Impact factor: 15.609

5. A phase-1b study of everolimus plus paclitaxel in patients with small-cell lung cancer.

Authors: J M Sun; J R Kim; I G Do; S Y Lee; J Lee; Y L Choi; J S Ahn; M J Ahn; K Park
Journal: Br J Cancer Date: 2013-08-20 Impact factor: 7.640

6. The Biological Role of PI3K Pathway in Lung Cancer.

Authors: Evangelos G Sarris; Muhammad W Saif; Kostas N Syrigos
Journal: Pharmaceuticals (Basel) Date: 2012-11-20

6 in total